
Delta-Fly Pharm
Delta-Fly Pharma develops new, affordable anticancer drugs with improved safety and efficacy using existing compounds, aiming to reduce side effects and alleviate the economic burden on patients and governments.
Market cap
$47.6m
Enterprise value
$45m
Share price
JPY665.00 4598.T
Authorizing premium user...